A WIDE-RANGING HEALTHCARE DEAL

The Department of Health - Abu Dhabi and Sanofi deal extends to four strategic healthcare priorities - hematology and oncology, rare metabolic diseases, diabetes management and vaccines. The partnership is part of ‘Abu Dhabi’s ongoing efforts to position itself as a leading life science destination and an innovation hub’.

Key activities will include the launch of a clinical research project and patient recruitment protocol. On hematology and oncology, DoH and Sanofi agreed to pursue creation of data generation and population research projects for late-stage breast cancer, liquid tumors and blood disorders.